Abstract
Hypertension is a serious health problem particularly for African-Americans. Previous studies have suggested that angiotensinogen (AGT) gene locus is involved in human essential hypertension. We have recently shown that an A/G polymorphism at −217 in the promoter of the AGT gene is associated with essential hypertension especially in African-Americans. We report here that A/G polymorphism at −217 affects the glucocorticoid-induced promoter activity of the human AGT gene. We show that recombinant glucocorticoid receptor (GR) binds strongly to the AGT gene promoter when nucleoside A is present at −217, and dexamethasone treatment increases the interleukin 6 induced promoter activity of reporter constructs containing nucleoside A at −217. Similarly cotransfection of GR and C/EBPβ or C/EBPδ increases the promoter activity of reporter construct containing nucleoside A at −217. Since AGT is an acute phase protein, we propose that increased expression of −217A allele of the AGT gene by glucocorticoids and C/EBP family of transcription factors may be involved in essential hypertension.
Similar content being viewed by others
Abbreviations
- AGT :
-
Angiotensinogen
- C/EBP :
-
CCAAT/enhancer-binding protein
- CBP :
-
CREB-binding protein
- CREB :
-
cAMP-response element binding protein
- GR :
-
Glucocorticoid receptor
- HEK :
-
Human embryonic kidney
- hr :
-
Human recombinant
- 11-β HSD :
-
11-β Hydroxysteroid dehydrogenase
- STAT :
-
Signal transducer and activator of transcription
References
Akira S et al (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9:1897–1906
Bloem LJ et al (1997) Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 29:1078–1082
Brasier AR, Han Y, Sherman CT (1999) Transcriptional regulation of angiotensinogen gene expression. Vitam Horm 57:217–247
Burt VL et al (1995) Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 25:305–313
Campbell DJ, Habener JF (1986) Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 78:31–39
Campbell DJ, Habener JF (1987) Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: quantification of messenger ribonucleic acid abundance using hybridization in situ. Endocrinology 121:1616–1626
Caulfield M et al (1995) Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 96:687–692
Corvol P, Jeunemaitre X (1997) Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev 18:662–677
Corvol P et al (1995) Role of the renin-angiotensin system in blood pressure regulation and in human hypertension: new insights from molecular genetics. Recent Prog Horm Res 50:287–308
Frederich RC Jr et al (1992) Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 19:339–344
Giacchetti G et al (2002) Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15:381–388
Glass CK, Rosenfeld MG (2000) The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14:121–141
Jain S et al (2002) Angiotensinogen gene polymorphism at −217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 277:36889–36896
Jeunemaitre X et al (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169–180
Kalinyak JE, Perlman AJ (1987) Tissue-specific regulation of angiotensinogen mRNA accumulation by dexamethasone. J Biol Chem 262:460–464
Kannel WB (2000) Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol 85:251–255
Kim HS et al (1995) Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92:2735–2739
Kimura S et al (1992) High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 11:821–827
Lynch KR, Peach MJ (1991) Molecular biology of angiotensinogen. Hypertension 17:263–269
Masuzaki H et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294 2166–2170
Matsuno F et al (1996) Induction of the C/EBP beta gene by dexamethasone and glucagon in primary-cultured rat hepatocytes. J Biochem (Tokyo) 119:524–532
Mosterd A et al (1999) Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 340:1221–1227
Narayanan CS, Cui Y, Kumar A (1998) DBP binds to the proximal promoter and regulates liver-specific expression of the human angiotensinogen gene. Biochem Biophys Res Commun 251:388–393
Narayanan CS et al (2000) cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor. Mol Cell Biochem 212 (1–2):81–90
Poli V (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273:29279–29282
Rask E et al (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86 [AB-3]:1418–1421
Rask E et al (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87:3330–3336
Ron D et al (1990) The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. Mol Cell Biol 10:4389–4395
Ron D et al (1990) An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol Cell Biol 10:1023–1032
Rotimi C et al (1994) Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 24:591–594
Saye JA et al (1989) Angiotensinogen gene expression in 3T3–L1 cells. Am J Physiol 256:C448–C451
Schindler C, Darnell JE Jr (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64:621–651
Sherman CT, Brasier AR (2001) Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin-6. Mol Endocrinol 15:441–457
Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697–738
Walker WG et al (1979) Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1:287–291
Ward R (1990) Familial aggregation and genetic epidemeology of blood pressure. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis and management. Raven, New York, pp 81–100
Wu SJ et al (2004) Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype vs. haplotype analysis. Physiol Genomics 17:79–86
Yang G et al (1994) Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem 269:32497–32502
Zhang Z et al (1997) STAT3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem 272:30607–30610
Acknowledgements
This work was supported by research grants HL 49884 and 59547 from the National Heart, Lung, and Blood Institute and from Philip-Morris Incorporated (to A.K.). We are thankful to Drs. K. Yamamoto, P. F. Johnson, and Steven McKnight for expression vectors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jain, S., Li, Y., Patil, S. et al. A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J Mol Med 83, 121–131 (2005). https://doi.org/10.1007/s00109-004-0621-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-004-0621-5